Levora Kit
Product Images NDC 51862-097

This is a chart displaying the range of blood clot incidents in non-pregnant individuals who are not using contraceptive pills (108), and postpartum individuals within 12 weeks after delivery. The chart presents data in a range, with the minimum value being 3109 for non-pregnant individuals and 401065 for postpartum individuals. It also shows the number of women out of 10,000 women years who had a blood clot. The rate for pregnancy is approximately 7 to 27 per 10,000 WY based on model assumptions that pregnancy lasts for nine months.*

This is a list of studies conducted on the use of contraceptive pills by women. The studies include the NICHD Women's Contraceptive Study, French E3N cohort study, Shanghai Women's Health Study, The Nurses' Health Study I and II, and the Oxford Family Planning Association Study. The studies evaluated the use of COCs (Combined Oral Contraceptives) and provide estimates marked as RR (relative risk), OR (odds ratio), and HR (hazard ratio). The description includes a definition of "ever use" and "never use" of COCs.*

This is a description of different contraceptive options and their effectiveness based on the number of pregnancies per 100 women in one year. It lists the effectiveness of various methods such as implants, injections, intrauterine devices (IUDs), sterilization, birth control pills, patches, vaginal rings with hormones, condoms, diaphragms, and natural family planning methods such as avoiding sex during the most fertile days and using spermicide or withdrawal.*

This is a medication called "et" that combines two active ingredients, Levonorgestrel 0.15 mg and Ethinyl Estradiol 0.03 mg. Unfortunately, there is not enough information to provide a useful description of this medication.*

Levora is an oral contraceptive medication used to prevent pregnancy, which contains levonorgestrel 0.15 mg and ethinyl estradiol 0.03 mg. The recommended daily dosage is one tablet per day. The medication is available in a 28-day regimen consisting of 21 white tablets and seven peach-colored tablets. The peach tablets do not contain any active ingredients. The complete prescribing information is included with the medication packet. Levora must be stored at a room temperature of 20-25°C (68-77°F), and it does not provide protection against HIV or other sexually transmitted diseases. The medication is manufactured and distributed by Mayne Pharma in Greenville, North Carolina.*